ATAI Price To Sales Ratio from 2010 to 2024

ATAI Stock  USD 1.33  0.03  2.21%   
ATAI Life's Price To Sales Ratio is increasing with slightly volatile movements from year to year. Price To Sales Ratio is predicted to flatten to 680.30. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing ATAI Life's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
713.23451226
Current Value
680.3
Quarterly Volatility
475.45558709
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ATAI Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ATAI Life's main balance sheet or income statement drivers, such as Tax Provision of 6.9 M, Interest Income of 1.4 M or Depreciation And Amortization of 334.9 K, as well as many indicators such as Price To Sales Ratio of 680, Dividend Yield of 0.0 or PTB Ratio of 0.97. ATAI financial statements analysis is a perfect complement when working with ATAI Life Valuation or Volatility modules.
  
Check out the analysis of ATAI Life Correlation against competitors.

Latest ATAI Life's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of ATAI Life Sciences over the last few years. Price to Sales Ratio is figured by comparing ATAI Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ATAI Life sales, a figure that is much harder to manipulate than other ATAI Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. ATAI Life's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ATAI Life's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 689.46 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

ATAI Price To Sales Ratio Regression Statistics

Arithmetic Mean259.55
Geometric Mean104.52
Coefficient Of Variation183.18
Mean Deviation319.02
Median60.17
Standard Deviation475.46
Sample Variance226,058
Range1.7K
R-Value0.57
Mean Square Error165,472
R-Squared0.32
Significance0.03
Slope60.17
Total Sum of Squares3.2M

ATAI Price To Sales Ratio History

2024 680.3
2023 713.23
2022 1777.74

About ATAI Life Financial Statements

Investors use fundamental indicators, such as ATAI Life's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although ATAI Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 713.23  680.30 

Currently Active Assets on Macroaxis

When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:
Check out the analysis of ATAI Life Correlation against competitors.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.97)
Earnings Share
(0.80)
Revenue Per Share
0.002
Quarterly Revenue Growth
(0.54)
Return On Assets
(0.25)
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.